BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Star Scientific , Inc. To Host Analyst And Investor Meeting


2/14/2014 9:56:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GLEN ALLEN, Va.
, Feb. 14, 2014 /PRNewswire/ -- Star Scientific, Inc., (NASDAQ: STSI) today announced that the Company will host an Analyst and Investor meeting for research analysts, and institutional and other investors, on Thursday, March 20, 2014, from 1:00 PM (EDT) to 3:00 PM in Sarasota, Florida, at the Roskamp Institute. Michael Mullan, M.D.(MBBS), Ph.D., Chairman and Chief Executive Officer of Star Scientific, along with Chris Chapman, M.D., President, will lead the Company's presentations. The presentations will focus on the scientific foundations of the Company's technology, the progress of its research and development programs, and the Company's near-term and long-term pharmaceutical strategy.

(Logo: http://photos.prnewswire.com/prnh/20130319/PH79245LOGO )

A live video webcast of the Analyst and Investor meeting will be accessible to the public through the Investor Relations section of Star Scientific's website at: http://www.starscientific.com/investors. Instructions relating to the electronic submission of questions from the webcast audience will be provided on the Company website as the meeting date approaches.

Registration is required to attend the meeting in Sarasota and seating is limited. Individuals interested in attending the meeting in person will be able to register, beginning February 19, 2014, through a link on the Company's website (www.starscientific.com).

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical dietary supplements products, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices and the outcome of the ongoing investigations as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended December 31, 2012 and our quarterly reports on Form 10-Q for the quarters ended March 31, 2013, June 30, 2013, and September 30, 2013. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.

About Star Scientific
Star Scientific, Inc. is a technology-oriented company with a mission to promote maintenance of a healthy metabolism and lifestyle. Through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been engaged in the manufacturing, sale, and marketing of two nutraceutical dietary supplements, a cosmetic facial cream, a facial serum, and the development of other nutraceuticals and pharmaceuticals. The company also continues to pursue the licensing of the technology behind its proprietary StarCuredĀ® curing process and its related products.

CONTACT:

Talhia T. Tuck
Vice President, Communications and Investor Relations
Star Scientific, Inc.
(202) 887-5100
ttuck@starscientific.com

Ted Jenkins
Vice President, Corporate Strategy and Development
Rock Creek Pharmaceuticals
tjenkins@rockcreekpharmaceuticals.com

SOURCE Star Scientific, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES